![](http://www.alamy.com/thumbs/6/F36D8847-85A6-482C-8307-99AB42EDA949/2ACNKNG.jpg)
Alemtuzumab antibody molecule. Computer model showing the molecular structure of the monoclonal antibody and cancer drug alemtuzumab. This antibody is
Alemtuzumab antibody molecule. Computer model showing the molecular structure of the monoclonal antibody and cancer drug alemtuzumab. This antibody is used as a drug in the treatment of chronic lymphocytic leukaemia (CLL), cutaneous T-cell lymphoma (CTCL) and T-cell lymphoma (TCL). It is also used in some conditioning regimens for bone marrow transplantation, kidney transplantation and Islet cell transplantation.
Size: 4197px × 4197px
Photo credit: © DR TIM EVANS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -cell, 1, alemtuzumab, anti-cancer, antibody, background, beta, biochemical, biochemistry, biological, biology, black, campath, campath-1h, cancer, cell, chemical, chemistry, chronic, cll, conditioning, ctcl, cutaneous, drug, drugs, immune, immunity, immunological, immunology, islet, kidney, lemtrada, leukaemia, leukemia, lymphocytic, lymphoma, mabcampath, model, molecular, molecule, monoclonal, oncological, oncology, pharmacological, pharmacology, protein, proteins, proteomics, ribbon, ribbons, secondary, sheet, sheets, single, structure, system, tcl, tertiary, therapy